SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-001901
Filing Date
2023-01-06
Accepted
2023-01-06 17:01:10
Documents
1
Period of Report
2023-01-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm232483-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm232483-2_4seq1.xml 4 3228
  Complete submission text file 0001104659-23-001901.txt   4942
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Issuer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LFB BIOTECHNOLOGIES, S.A.S. 3, AVENUE DES TROPIQUES LES ULIS COURTABOEUF I0 91958
Business Address
Echelard Yann (Reporting) CIK: 0001561958 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32639 | Film No.: 23515775